Puma Biotechnology | PBYI - Devedores Comerciais





Devedores Comerciais Alterar Data
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
Exelixis USD 322.21M 6.73M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Incyte USD 1.13B 73.7M 2026-06
MacroGenics USD 10.42M 2.95M 2026-03
Moderna USD 17M 54M 2026-06
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Takeda JPY 956.14B 79.79B 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06